Source-grounded facts extracted from Xtant Medical Holdings, Inc.'s SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
Xtant Medical Holdings, Inc. shareholders approved Advisory vote on executive compensation at the 2022-10-26 meeting.
“Proposal No. 3 - The compensation of the Company’s executive officers named in the proxy statement was approved, on an advisory basis, by the following final voting results: Votes For Votes Against Votes Abstained Broker Non-Votes 82,804,076 56,671 6,693 2,002,504”
Xtant Medical Holdings, Inc. shareholders approved Ratification of appointment of independent registered public accounting firm at the 2022-10-26 meeting.
“Proposal No. 2 - The ratification of the appointment of Plante & Moran, PLLC as the Company’s independent registered public accounting firm for the year ending December 31, 2022 was approved by the following final voting results: Votes For Votes Against Votes Abstained Broker Non-Votes 84,845,095 12,191 12,658 0”
Xtant Medical Holdings, Inc. shareholders approved Election of six director nominees at the 2022-10-26 meeting.
“Proposal No. 1 - The six director nominees proposed by the Board were elected to serve as members of the Board until the next annual meeting of stockholders and until their respective successors have been duly elected and qualified by the following final voting results: Votes For Votes Withheld Broker Non-Votes John Bakewell 82,400,159 467,281 2,002,504 Sean E. Browne 81,806,196 1,061,244 2,002,504 Michael Eggenberg 81,755,204 1,112,236 2,002,504 Robert McNamara 82,387,100 480,340 2,002,504 Matthew Rizzo 81,755,616 1,111,824 2,002,504 Stavros Vizirgianakis 81,782,213 1,085,227 2,002,504”
Jeffrey Peters changed role as Chairman of the Board at Xtant Medical Holdings, Inc..
“the Board elected Mr. Vizirgianakis as Chairman of the Board, effective upon completion of the First Closing, to replace Jeffrey Peters, who previously served as Chairman of the Board and intends not to stand for re-election at the Company’s next annual meeting of stockholders”
Stavros Vizirgianakis was appointed as Chairman of the Board at Xtant Medical Holdings, Inc..
“the Board elected Mr. Vizirgianakis as Chairman of the Board, effective upon completion of the First Closing, to replace Jeffrey Peters, who previously served as Chairman of the Board and intends not to stand for re-election at the Company’s next annual meeting of stockholders”
Jeffrey Peters changed role as Chairman of the Board at Xtant Medical Holdings, Inc..
“to replace Jeffrey Peters, who is currently serving as Chairman of the Board and intends not to stand for re-election at the Company's next annual meeting of stockholders”
Scott C. Neils was appointed as Chief Financial Officer at Xtant Medical Holdings, Inc..
“On April 27, 2022, the Board of Directors of Xtant Medical Holdings, Inc. (the “Company”) approved the appointment of Scott C. Neils as non-interim Chief Financial Officer, effective June 1, 2022.”
Scott Neils was appointed as Interim Chief Financial Officer at Xtant Medical Holdings, Inc..
“announced the appointment of Scott Neils as Interim Chief Financial Officer”
Greg Jensen was terminated as Vice President, Finance and Chief Financial Officer at Xtant Medical Holdings, Inc..
“whose employment terminated effective as of January 3, 2022.”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.